Insider · CIK 0001515806

Eisenstadt Richard I

Reports to the SEC for 4 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001515806

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-01-31	ALTAltimmune, Inc.A Award	Chief Financial Officer	AAward	+4,621 sh	$2.69	+$12.4K	45,012
2024-01-30	ALTAltimmune, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+9,275 sh	—	—	42,566
2024-01-30	ALTAltimmune, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−2,175 sh	$9.80	−$21.3K	40,391
2024-01-30	ALTAltimmune, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−9,275 sh	—	—	27,825
2024-01-25	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Chief Financial Officer	AAward	+163K sh	—	—	163,200
2024-01-25	ALTAltimmune, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+58.4K sh	—	—	58,400
2023-12-29	ALTAltimmune, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12.5K sh	—	—	36,335
2023-12-29	ALTAltimmune, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−3,044 sh	$11.25	−$34.2K	33,291
2023-12-29	ALTAltimmune, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12.5K sh	—	—	25,000
2023-07-31	ALTAltimmune, Inc.A Award	Chief Financial Officer	AAward	+1,825 sh	$2.81	+$5,128.25	23,835
2023-03-24	ALTAltimmune, Inc.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$4.31	+$43.1K	22,010
2023-01-31	ALTAltimmune, Inc.A Award	Chief Financial Officer	AAward	+1,172 sh	$10.21	+$12K	12,010
2023-01-30	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Chief Financial Officer	AAward	+105K sh	—	—	105,000
2023-01-30	ALTAltimmune, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+37.1K sh	—	—	37,100
2022-12-31	ALTAltimmune, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12.5K sh	—	—	13,866
2022-12-31	ALTAltimmune, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−3,028 sh	$16.45	−$49.8K	10,838
2022-12-31	ALTAltimmune, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12.5K sh	—	—	37,500
2022-07-31	ALTAltimmune, Inc.A Award	Chief Financial Officer	AAward	+1,366 sh	$6.86	+$9,370.76	1,366
2021-12-31	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Chief Financial Officer	AAward	+150K sh	—	—	150,000
2021-12-31	ALTAltimmune, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2021-03-31	AYTUAYTU BIOPHARMA, INCA Award	Chief Financial Officer	AAward	+55K sh	—	—	68,734
2021-03-19	Neos Therapeutics, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−126K sh	—	—	0
2021-03-19	Neos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−86.2K sh	—	—	0
2021-03-19	Neos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−12.5K sh	—	—	0
2021-03-19	Neos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−60.2K sh	—	—	0
2021-03-19	Neos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−50K sh	—	—	0
2021-03-19	Neos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−45K sh	—	—	0
2021-03-19	Neos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−56.3K sh	—	—	0
2021-03-19	Neos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−230K sh	—	—	0
2021-03-19	Neos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−115K sh	—	—	0
2021-03-02	Neos Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−14.8K sh	$0.84	−$12.5K	126,245
2021-03-01	Neos Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−1,390 sh	$0.88	−$1,227.37	141,070
2020-03-02	Neos Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+100K sh	—	—	—
2020-03-02	Neos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+115K sh	—	—	115,000
2019-03-01	Neos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+230K sh	—	—	230,276
2018-12-12	Neos Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$2.16	+$10.8K	42,460
2018-03-01	Neos Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+18.8K sh	—	—	37,460
2018-03-01	Neos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+56.3K sh	—	—	56,250
2017-05-01	Neos Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+15K sh	—	—	18,710
2017-05-01	Neos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+45K sh	—	—	45,000
2016-08-25	Neos Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+3,710 sh	$6.82	+$25.3K	3,710
2016-04-01	Neos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2015-09-01	Neos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+60.2K sh	—	—	60,230
2012-08-07	Ocera Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	VP, Finance & CFO	AAward	+40K sh	—	—	40,000
2011-04-19	Ocera Therapeutics, Inc.Stock Option (right to buy)A Award	VP, Finance & CFO	AAward	+149K sh	—	—	148,736

Recent filings

Accepted (ET)
Feb 14
Eisenstadt Richard I0001104659-24-009538
SEC(opens sec.gov)
Jan 294
Eisenstadt Richard I0001104659-24-007859
SEC(opens sec.gov)
Jan 24
Eisenstadt Richard I0001104659-24-000424
SEC(opens sec.gov)
Aug 24
Eisenstadt Richard I0001104659-23-086907
SEC(opens sec.gov)
Mar 244
Eisenstadt Richard I0001104659-23-036758
SEC(opens sec.gov)
Feb 24
Eisenstadt Richard I0001104659-23-009972
SEC(opens sec.gov)
Feb 14
Eisenstadt Richard I0001104659-23-009353
SEC(opens sec.gov)
Jan 34
Eisenstadt Richard I0001104659-23-000469
SEC(opens sec.gov)
Aug 34
Eisenstadt Richard I0001104659-22-085617
SEC(opens sec.gov)
Jan 44
Eisenstadt Richard I0001104659-22-000629
SEC(opens sec.gov)

Companies

Address

C/O TRANZYME, INC. 4819 EMPEROR BOULEVARD, SUITE 400

DURHAM, NC, 27703